Verisign Downgraded to Neutral at Credit Suisse (VRSN)

Credit Suisse cut shares of Verisign (NASDAQ: VRSN) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning. The firm currently has $42.50 price target on the stock.

“The recent decision on the .com renewal agreement to maintain .com pricing at $7.85 with no price increases in the next six years has largely capped upside to revenue estimates to growth in the installed base of .com and .net domain names in the near term. Although we expect VeriSign to continue to steadily improve margins with consistent revenue growth driven by net additions to the .com and .net registries, we view the incremental revenue growth catalysts of new gTLDs and the company’s IP licensing strategy as unlikely to meaningfully contribute to revenue until 2014 at the earliest.,” Credit Suisse’s analyst commented.

Shares of Verisign opened at 45.81 on Wednesday. Verisign has a 52 week low of $32.81 and a 52 week high of $50.15. The stock’s 50-day moving average is currently $43.21. The company has a market cap of $7.027 billion and a P/E ratio of 23.42.

VRSN has been the subject of a number of other recent research reports. Analysts at Zacks upgraded shares of Verisign from a neutral rating to an outperform rating in a research note to investors on Friday, February 22nd. They now have a $54.00 price target on the stock. Separately, analysts at Topeka Capital Markets raised their price target on shares of Verisign to $52.00 in a research note to investors on Tuesday, February 5th.

Three analysts have rated the stock with a buy rating, twelve have given a hold rating, and one has assigned an underweight rating to the company. Verisign has a consensus rating of hold and an average price target of $41.69.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Leave a Reply

Recent Stories

New Vaccine for Flu Works on Animals
New Vaccine for Flu Works on Animals
Acquaintance of Boston Bombing Suspect Fatally Shot by FBI
Acquaintance of Boston Bombing Suspect Fatally Shot by FBI
Liver Disease Risk Might be Lowered by Drinking Coffee
Liver Disease Risk Might be Lowered by Drinking Coffee
Construction Workers in Dubai Strike for Better Pay and Overtime
Construction Workers in Dubai Strike for Better Pay and Overtime
Bashar al-Assad says no to Stepping Down as Syria President
Bashar al-Assad says no to Stepping Down as Syria President
CDC: Mental Disorders affect close to 1 out of 5 Children
CDC: Mental Disorders affect close to 1 out of 5 Children
© 2010-2013 The Utah People's Post, Inc. · RSS. · Subscribe Subscribe